Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials

AIMS: To examine the albuminuria‐lowering effect of exenatide once weekly (EQW) compared with active glucose‐lowering comparators in patients with type 2 diabetes and elevated urinary albumin‐to‐creatinine ratio (uACR). METHODS: Six randomized double‐blind and open‐label phase III studies were poole...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Aart ‐ van der Beek, Annemarie B., van Raalte, Daniel H., Guja, Cristian, Hoogenberg, Klaas, Suchower, Lisa J., Hardy, Elise, Sjöström, C. David, Heerspink, Hiddo J.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496075/
https://www.ncbi.nlm.nih.gov/pubmed/32329160
http://dx.doi.org/10.1111/dom.14067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496075/
https://www.ncbi.nlm.nih.gov/pubmed/32329160
http://dx.doi.org/10.1111/dom.14067

Ejemplares similares